pre-seed
Stage
1
Investors
About
Cellsway develops a patented microfluidic circulating tumor cell (CTC) enrichment and identification platform enabling minimally invasive cancer monitoring and patient profiling from blood samples.
Explore Cellsway's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.